120 related articles for article (PubMed ID: 26231933)
1. In situ Fourier transform infrared analysis of live cells' response to doxorubicin.
Fale PL; Altharawi A; Chan KL
Biochim Biophys Acta; 2015 Oct; 1853(10 Pt A):2640-8. PubMed ID: 26231933
[TBL] [Abstract][Full Text] [Related]
2. Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines.
Krishna CM; Kegelaer G; Adt I; Rubin S; Kartha VB; Manfait M; Sockalingum GD
Biopolymers; 2006 Aug; 82(5):462-70. PubMed ID: 16493658
[TBL] [Abstract][Full Text] [Related]
3. Towards identifying the mode of action of drugs using live-cell FTIR spectroscopy.
Altharawi A; Rahman KM; Chan KLA
Analyst; 2019 Apr; 144(8):2725-2735. PubMed ID: 30865733
[TBL] [Abstract][Full Text] [Related]
4. Role of glutathione S-transferases in the resistance of human colon cancer cell lines to doxorubicin.
Beaumont PO; Moore MJ; Ahmad K; Payne MM; Lee C; Riddick DS
Cancer Res; 1998 Mar; 58(5):947-55. PubMed ID: 9500455
[TBL] [Abstract][Full Text] [Related]
5. Mitochondrial amplification selectively increases doxorubicin sensitivity in breast cancer cells with acquired antiestrogen resistance.
Skildum A; Dornfeld K; Wallace K
Breast Cancer Res Treat; 2011 Oct; 129(3):785-97. PubMed ID: 21128112
[TBL] [Abstract][Full Text] [Related]
6. Fourier transform infrared spectroscopy for the distinction of MCF-7 cells treated with different concentrations of 5-fluorouracil.
Wu BB; Gong YP; Wu XH; Chen YY; Chen FF; Jin LT; Cheng BR; Hu F; Xiong B
J Transl Med; 2015 Apr; 13():108. PubMed ID: 25884618
[TBL] [Abstract][Full Text] [Related]
7. Classification and structural analysis of live and dead Salmonella cells using Fourier transform infrared spectroscopy and principal component analysis.
Sundaram J; Park B; Hinton A; Yoon SC; Windham WR; Lawrence KC
J Agric Food Chem; 2012 Feb; 60(4):991-1004. PubMed ID: 22257216
[TBL] [Abstract][Full Text] [Related]
8. FTIR microspectroscopy defines early drug resistant human hepatocellular carcinoma (HepG2) cells.
Junhom C; Weerapreeyakul N; Tanthanuch W; Thumanu K
Exp Cell Res; 2016 Jan; 340(1):71-80. PubMed ID: 26708618
[TBL] [Abstract][Full Text] [Related]
9. Electrospun nanofibrous mats containing quaternized chitosan and polylactide with in vitro antitumor activity against HeLa cells.
Ignatova MG; Manolova NE; Toshkova RA; Rashkov IB; Gardeva EG; Yossifova LS; Alexandrov MT
Biomacromolecules; 2010 Jun; 11(6):1633-45. PubMed ID: 20469930
[TBL] [Abstract][Full Text] [Related]
10. Attenuated total reflection Fourier transform infrared (ATR-FTIR) spectroscopy of a single endothelial cell.
Wrobel TP; Marzec KM; Majzner K; Kochan K; Bartus M; Chlopicki S; Baranska M
Analyst; 2012 Sep; 137(18):4135-9. PubMed ID: 22854681
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of exosome release by ketotifen enhances sensitivity of cancer cells to doxorubicin.
Khan FM; Saleh E; Alawadhi H; Harati R; Zimmermann WH; El-Awady R
Cancer Biol Ther; 2018 Jan; 19(1):25-33. PubMed ID: 29244610
[TBL] [Abstract][Full Text] [Related]
12. Cell discrimination by attenuated total reflection-Fourier transform infrared spectroscopy: the impact of preprocessing of spectra.
Gaigneaux A; Ruysschaert JM; Goormaghtigh E
Appl Spectrosc; 2006 Sep; 60(9):1022-8. PubMed ID: 17002828
[TBL] [Abstract][Full Text] [Related]
13. pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells.
Shalviri A; Raval G; Prasad P; Chan C; Liu Q; Heerklotz H; Rauth AM; Wu XY
Eur J Pharm Biopharm; 2012 Nov; 82(3):587-97. PubMed ID: 22995704
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA Profile in Response to Doxorubicin Treatment in Breast Cancer.
Tormo E; Pineda B; Serna E; Guijarro A; Ribas G; Fores J; Chirivella E; Climent J; Lluch A; Eroles P
J Cell Biochem; 2015 Sep; 116(9):2061-73. PubMed ID: 25802200
[TBL] [Abstract][Full Text] [Related]
15. Identifying the Responses from the Estrogen Receptor-Expressed MCF7 Cells Treated in Anticancer Drugs of Different Modes of Action Using Live-Cell FTIR Spectroscopy.
Altharawi A; Rahman KM; Chan KLA
ACS Omega; 2020 Jun; 5(22):12698-12706. PubMed ID: 32548453
[TBL] [Abstract][Full Text] [Related]
16. Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells.
Efferth T; Giaisi M; Merling A; Krammer PH; Li-Weber M
PLoS One; 2007 Aug; 2(8):e693. PubMed ID: 17668070
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial delivery of doxorubicin via triphenylphosphine modification for overcoming drug resistance in MDA-MB-435/DOX cells.
Han M; Vakili MR; Soleymani Abyaneh H; Molavi O; Lai R; Lavasanifar A
Mol Pharm; 2014 Aug; 11(8):2640-9. PubMed ID: 24811541
[TBL] [Abstract][Full Text] [Related]
18. Monitoring of apoptosis of HL60 cells by Fourier-transform infrared spectroscopy.
Gasparri F; Muzio M
Biochem J; 2003 Jan; 369(Pt 2):239-48. PubMed ID: 12383054
[TBL] [Abstract][Full Text] [Related]
19. Anticancer medicines (Doxorubicin and methotrexate) conjugated with magnetic nanoparticles for targeting drug delivery through iron.
Samra ZQ; Ahmad S; Javeid M; Dar N; Aslam MS; Gull I; Ahmad MM
Prep Biochem Biotechnol; 2013; 43(8):781-97. PubMed ID: 23876138
[TBL] [Abstract][Full Text] [Related]
20. p300 mediates cellular resistance to doxorubicin in bladder cancer.
Takeuchi A; Shiota M; Tatsugami K; Yokomizo A; Tanaka S; Kuroiwa K; Eto M; Naito S
Mol Med Rep; 2012 Jan; 5(1):173-6. PubMed ID: 21935574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
